2018 Public Health Recognition – Jewish Family Services of Delaware

At the 88th Annual Meeting of the Delaware Academy of Medicine / Delaware Public Health Association the work of Jewish Family Services of Delaware was accepted by their CEO, Basha Silverman.

Started by the Delaware Academy of Medicine in 2010, the Public Health Recognition Award is given to a Delaware nonprofit organization who has shown outstanding leadership and dedication to the improvement of our community.

Previous awardees include:

  • 2010 The Heart Truth Delaware
  • 2011 Delaware Breast Cancer Coalition
  • 2012 Immunization Coalition of Delaware
  • 2013 St. Michael’s School and Nursery
  • 2014 Vietnam Veterans of America, Chapter 83, Gold Star Program
  • 2015 Gift of Life Donor Program
  • 2016 Hon. Jack Markell – Governor of Delaware 2009-2017
  • 2017 American Lung Association of the Mid-Atlantic

Jewish Family Services of Delaware (JFS) is multi-faceted social service organization that embraces and fulfills a mission to strengthen individuals, families, and the community by providing counseling and support services. Our services include outpatient therapy, case management, workforce development, refugee resettlement, adoption, and prevention education. Our work has been accomplished person-by person, need by need and always with compassion, skill and commitment to individual integrity.

As a result, our agency today is strong and stable. Our programs and policies are designed to remove barriers that may inhibit people in vulnerable situations from accessing needed support. We are all responsible for one another. Inspired by this fundamental Jewish value, Jewish Family Services assists individuals and families through life transitions, helping youth and children grow stronger, and ensuring the safety and dignity of older adults. JFS supports families of all backgrounds as they deal with basic human needs, life transitions, and mental health issues. JFS has the unique privilege of representing the tzedakah (justice), compassion, and loving kindness of the Jewish people to the broader community. Many JFS clients are not Jewish, but all of them learn what it means to be Jewish: the beauty of our traditions and our commitment to tikkun olam, building a better world.

Basha Silverman, Chief Executive Officer of Jewish Family Services of Delaware, has an exemplary career of over 16 years in non-profit social services and Jewish communal service.

Prior to joining JFS, Basha was the Vice President of Strategic Expansion at Jewish Family & Children’s Services of Philadelphia where she was responsible for driving the Agency’s program development and visions for growth as well as generating revenue by leading a robust initiative. A native Delawarean, Basha has deep personal and professional connections in the First State. She spent 12 years at Brandywine Counseling and Community Services, serving in many capacities. She is founder of Delaware’s first coalition aimed at designing a gender specific, health focused response to victims of trauma, and has developed programs for HIV/AIDS, substance abuse, and mental health in Delaware and Pennsylvania. She was named 2013 Power Woman of the Year by Main Line Magazine.

Basha is a graduate of Brandywine High School, University of Delaware, and Bryn Mawr Graduate School of Social Work and Social Research. She and her husband Jesse have two daughters, Noa and Mira.

2018 Lewis B. Flinn President’s Award – Nicholas Petrelli, MD, FACS

At the 88th Annual Meeting of the Delaware Academy of Medicine / Delaware Public Health Association, Dr. Nicholas Petrelli was honored with the Academy’s highest award named in honor of Lewis B. Flinn, first president of the Academy of Medicine.

Over the past 18 years, Dr. Petrelli has been a nationally recognized leader in the fight against cancer and developed the Helen F. Graham Cancer Center & Research Institute into a national model of cancer care, prevention, outreach and research.

Thanks to Dr. Petrelli’s leadership and partnerships with others in the state and elsewhere, Delaware’s cancer mortality rate is now dropping twice as fast as the national rate. The state is outpacing the nation in reducing deaths from a number of cancers, including breast cancer and colorectal cancer. The State has gone from number one in cancer mortality to number 18. Among his many accomplishments:

• Established the Helen F. Graham Cancer Center & Research Institute as one of the first cancer centers in the nation selected for the National Cancer Institute Community Centers Program that helped to shape the way cancer care is delivered across the country.

• Through an unprecedented public-private partnership, the Helen F. Graham Cancer Center & Research Institute was integral in making sure all people in Delaware receive care for cancer no matter their income level or health insurance status.

• Led the development of 14 multidisciplinary disease site centers and selection as one of three community cancer centers to participate in the Cancer Genome Atlas Project.

•Achieved one of the highest National Cancer Institute clinical trials participation rates in the country at 24 percent, well above the national rate of 4 percent.

• Developed the first statewide High Risk Family Cancer Registry, consisting of 7,000 families with more than 250,000 individuals and the recruitment of seven full-time genetic counselors.

• Established an historic research partnership with The Wistar Institute of Philadelphia, the first time an NCI-designated basic science center has aligned with an independent academic community cancer center on translational cancer research with the aim of bringing the latest discoveries in cancer research to cancer patients in our community.

• Established the Center for Translational Cancer Research, 7,000 sq. ft. of laboratory space where scientists and clinicians work together to find new cancer treatments.

• Established the Gene Editing Institute, a worldwide leader in gene editing and biomedical research in cancer and other inherited diseases, and the only one in the U.S. embedded in a clinical center where interactions among oncologists, genetic counselors and patients take place.

Dr. Petrelli has received numerous awards and has authored 343 peer-reviewed manuscripts. He has served on several advisory panels of the National Cancer Institute, the American Society of Clinical Oncology, the American Cancer Society and the Society of Surgical Oncology. He was President of the Society of Surgical Oncology 2007-2008. In 2013, he received the Order of the First State Award by Governor Jack Markell for his dedication to excellence in serving the community and the State of Delaware.

Previous recipients include:

2008 Victor F. Battaglia, Sr., Esq.
2009 Robert W. Frelick, M.D.
2010 Leslie W. Whitney, M.D.
2011 Robert B. Flinn, M.D.
2012 Edwin L. Granite, D.M.D.
2013 Katherine L. Esterly, M.D.
2014 LTG(DE) William H. Duncan, M.D.
2015 Joseph A. Kuhn, M.D.
2016 J. Kent Riegel, Esq.
2017 Hon. Susan C. Del Pesco

Smartphone CPR App in New Castle County

Leaders in New Castle County, Delaware, have launched a new smartphone application they say will save lives when help is urgently needed.

Activated when a call is made to 911, the PulsePoint app alerts and directs trained residents to people nearby who need cardiopulmonary resuscitation or CPR. County Executive Matt Meyer said citizen responders, who include off-duty first responders, can make all the difference in those critical moments before first responders arrive.

Learn more

Christiana Care Medical Aid Units

Five Christiana Care Medical Aid Units (CCMAU) are now available for convenient care, 7 days a week! Most are open from 8:00 am to 8:00 pm, and no appointment is necessary.  Express Check-In (available on christianacare.org) enables people to see current wait times and reserve their spot in line.

When you should go:

If you have an illness or injury that are NOT extremely serious or life-threatening, but DO require care within a few hours or the same day
(game day sports injuries, sore throats & coughs, eye & ear problems, minor burns, flu-like symptoms, etc.)

5 Convenient MAU Locations

Star Campus
550 South College Avenue
Suite 115
Newark, DE 19713
302-533-7148

Smyrna Health & Wellness Center
100 S. Main Street
Smyrna, DE 19977
302-659-4444

Glasgow Medical Center
2600 Glasgow Avenue
Newark, DE 19702
302-836-8350

Middletown Care Center
124 Sleepy Hollow Drive
Middletown, DE 19709
302-449-3100

HealthCare Center at Christiana
200 Hygeia Drive
Newark, DE 19713
302-623-0444

Addiction Resources in Delaware

Over 20 million Americans had a substance abuse disorder in 2015.  It is the leading cause of accidental death in the United states, and over 20,000 of those overdose deaths are related to prescription pain relievers (American Society of Addiction Medicine).

Addiction is everywhere, even in Delaware.

SO IS HELP. 

Visit HelpIsHereDE.com

New Castle County: 800-652-2929

Kent & Sussex Counties: 800-345-6785

Innovative Discoveries Series

Law, Technology, and End-of-Life Planning

Advance directives (AD) were created as legal documents to help ensure that patients’ wishes are respected at the end of life.  However, their actual impact on end-of-life care is less clear.  Most people do not complete them, and they are often unavailable when needed.  Recent technological innovations have sought to reinvent ADs.  Tech start-ups offer tools to create and store digital ADs, and commercial electronic health record systems are expanding their functionality to store end-of-life wishes.  I trace the history of ADs, discuss the limitations of the legal model, and describe current efforts to digitize end-of-life planning.  I will focus in part on efforts at the University of Pennsylvania to develop an EHR-integrated online platform for documenting end-of-life plans.

Presented By:

Joshua Rolnick, MD, JD

General Internist and VA Advanced Fellow, National Clinician Scholars Program, University of Pennsylvania/Philadelphia VA Medical Center

Free!  Lunch will be served!

This activity has been approved for AMA PRA Category 1 Credit.

REGISTER ONLINE TODAY!

Friday, December 14, 2018
Noon to 1 p.m.
In-person: Christiana Hospital,Room 110
Online: Watch live at https://bluejeans.com/361095905
Or join meeting ID 361095905 on the BlueJeans app on your smartphone or tablet

This activity has been approved for AMA PRA Category 1 Credit.

Upcoming Lectures:

January 11, 2019: Beyond Rants, Raves, and Reputation: Using Patient Comments to Improve Care

Statement on Vaccines

Vaccines Continue to be Tested and Proven Safe

American Academy of Pediatrics. (2017). American Academy of Pediatrics Emphasizes Safety and Importance of Vaccines. Retrieved from https://www.aap.org/en-us/about-the-aap/aap-press-room/Pages/American-Academy-of-Pediatrics-Emphasizes-Safety-and-Importance-of-Vaccines.aspx

Centers for Disease Control and Prevention. (2016). Infant Immunizations FAQs. Retrieved from https://www.cdc.gov/vaccines/parents/parent-questions.html

Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. Retrieved from https://www.nap.edu/catalog/10997/immunization-safety-review-vaccines-and-autism

U.S. Food and Drug Administration. (2015).  Thimerosal in Vaccines: Questions and Answers. Retrieved from http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/UCM070430#q5

In light of recent claims by politicians or appointees that vaccines are linked to autism, or are unsafe when administered according to the recommended schedule, or contain dangerous products like Thimerosal, the public health community and the Delaware Academy of Medicine/Delaware Public Health Association continue to come down on the side of science.

The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research is responsible for regulating vaccines in the United States.  Before a vaccine can be licensed for public use, it must be tested for safety in the laboratory, in animals, and in human clinical trials.  Human clinical trials include looking for common adverse events in a few participants (phase 1), several hundred volunteers looking for local reactions and general side effects like fever (phase 2), and establishing the effectiveness of the vaccine and determining less common side effects with thousands of participants (phase 3).  If a vaccine is to be given at the same time as another vaccine, the two vaccines are tested together (FDA, 2015).  If a dangerous effect is found, that vaccine is not licensed for public use.

Vaccines are continuously monitored following licensure by the Vaccine Adverse Event Reporting System (VAERS), which is run by both the FDA and the Centers for Disease Control (CDC).  The VAERS is a national system that collects all reports of adverse events following vaccination.  Phase 4 clinical studies are also conducted to further evaluate the new vaccine, and population based studies are conducted through the use of databases like the Vaccine Safety Datalink (VSD) for the lifetime of the use of the vaccine (FDA, 2015).

The Institute of Medicine (IOM) Immunization Safety Review Committee “favors rejection of a causal relationship between thimerosal-containing vaccines and autism” (IOM, 2004).  Despite this finding, “all vaccines routinely recommended for children 6 years of age or younger and marketed in the U.S. contain no thimerosal or only trace amounts” (FDA, 2015).

“Infants and young children who follow immunization schedules that spread out shots – or leave out shots – are at risk of developing diseases during the time that shots are delayed” (CDC, 2016). Vaccines “keep communities healthy, and protect some of the most vulnerable in our society” (American Academy of Pediatrics, 2017).  The Delaware Academy of Medicine will continue to advocate for vaccines and vaccine use in the state of Delaware and the United States.